Advertisement

Topics

National Stem Cell Holding, Inc. Company Profile

12:12 EDT 22nd March 2019 | BioPortfolio

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived from stem cells. For more information, visit http://www.proteoderm.com, and http://www.proteonomix.com.


News Articles [3331 Associated News Articles listed on BioPortfolio]

The Puzzle of Stem Cells and Cancer Stem Cells: The MIT Stem Cell Initiative

The Puzzle of Stem Cells and Cancer Stem Cells: The MIT Stem Cell Initiative Reporter: Irina Robu, PhD The MIT Stem Cell Initiative is looking to research fundamental biological questions about norma...

The Puzzle of Stem Cells

The Puzzle of Stem Cells Reporter: Irina Robu, PhD The MIT Stem Cell Initiative is looking to research fundamental biological questions about normal adult stem cells and their malignant counterparts, ...

Stem Cell Sciences: Stem Cell Technologies: The End of the Beginning

In this exclusive interview, Fintan Walton talks to Peter Mountford, formerly CEO of Stem Cell Sciences, about the current state of stem cell technologies and their potential healthcare and research a...

NHLBI Halts Heart Failure Study After Retracted Papers Raise Concern Over Controversial Stem Cell...

In the wake of a significant number of journal articles being retracted due to falsified data, the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, is halting a cl...

Progress in stem cell science and regenerative medicine on tap in Los Angeles, June 26-29

(International Society for Stem Cell Research) Top scientists and researchers from academia, medicine, and industry will share groundbreaking stem cell science and its translation to clinical applicat...

Media Advisory: The New York Stem Cell Foundation Conference

(New York Stem Cell Foundation) The New York Stem Cell Foundation (NYSCF)'s 13th annual translational stem cell research conference convenes global leaders in stem cell research to present their lates...

This Biotech Accelerates Stem Cell Therapy Development

Mogrify is the new kid on the block for stem cell therapy. Based in Cambridge, UK, it boasts technology that could speed up the development of stem cell therapies by predicting the best protein recipe...

Investing in Stem Cell Treatments

Stem cell treatments have grabbed investor attention for years, but can be be complex and a dangerous treatment. Here is an overview of investing in stem cell treatments. The post Investing in Stem Ce...

PubMed Articles [6007 Associated PubMed Articles listed on BioPortfolio]

Setting our AdipoSIGHTS on Stem Cells in Pharmacogenomics.

In a recent study published in Cell Stem Cell, Hu et al. (2019) used human adipose stem cell-derived adipocytes to demonstrate that genetic variation predicts anti-diabetic response to thiazolidinedi...

Competition for Food Drives Stem Cell Fate in Facultative Niches.

Mechanisms regulating maintenance of the stem cell pool in facultative niches of the mammalian testis are poorly understood. In this issue of Cell Stem Cell, Kitadate et al. (2019) propose a minimal ...

Spatiotemporal Resolution of SCF Supply in Early Hematopoiesis.

Evidence suggests that hematopoietic progenitor cells self-replenish in situ over prolonged time frames, centering the question on the identity and source of growth factors maintaining HPC fidelity. I...

Stem Cell Aging? Blame It on the Niche.

The molecular basis for the neural stem cell quiescence-to-activation transition has become an important focus in the study of adult neurogenesis. Recently in Cell, Kalamakis et al. (2019) show that ...

Women in Stem Cell Science: Part I.

Female scientists play important leadership roles in the field and with the International Society for Stem Cell Research. We asked a number of these top researchers to share their personal stories and...

Clinical Trials [9725 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Prevention of Radiation Pneumonitis After Three-Dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-Small-Cell Lung Cancer

The purpose of this study is to evaluate the interest of breath holding for the prevention of radiation pneumonitis following conformal radiation therapy. Eligible patients will be random...

Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula

This observational study aims at assessing the safety and efficacy profiles of mesenchymal stem cell, in different formats (SVF, autologous, allogenic), to treat complex perianal fistula a...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Companies [2421 Associated Companies listed on BioPortfolio]

National Stem Cell Holding, Inc.

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived ...

National Stem Cell Foundation

The National Stem Cell Foundation (NSCF) is a charitable 501(c)3 organization that funds adult stem cell and regenerative medicine research to accelerate treatment options, advoca...

Stem Cell Assurance, Inc.

Stem Cell Assurance, Inc. is the first company in the US to provide full-spectrum adult stem cell services to consumers through a national physician network. The company offers ge...

America Stem Cell, Inc.

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of s...

Cellectis Group

Cellectis stem cells, is a business unit within the Cellectis group and is a global leader in stem cell technology. Cellectis stem cells, created in November 2011 from Cellartis A...

More Information about "National Stem Cell Holding, Inc." on BioPortfolio

We have published hundreds of National Stem Cell Holding, Inc. news stories on BioPortfolio along with dozens of National Stem Cell Holding, Inc. Clinical Trials and PubMed Articles about National Stem Cell Holding, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of National Stem Cell Holding, Inc. Companies in our database. You can also find out about relevant National Stem Cell Holding, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record